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ABSTRACT
A new internal cross-validation method is presented for assessing the true predictive capability of QSAR models. The test is general and can be applied in 
many QSAR/QSPR approaches. In this work, the method is tested on a well-known benchmark set of steroids. In order to make the calculations, Topological 
Quantum Similarity Indices and Multiple Linear Regression models were considered.
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INTRODUCTION
One of the crucial steps involved in a QSPR/QSAR study consists of the 
statistical validation of results. Some of the most popular validation techniques 
are the well-known Leave-one-out (LOO) and Leave-many-out (LMO) cross-
validation (CV) procedures1-4. A good cross-validation method must be an 
honest and transparent procedure. Wold3,4 warned that these simple aspects of 
paramount importance for method reliability must be well taken care of. In 
this work an internal validation method inspired by the concept of the external 
validation test set is described. The method is general and applicable to many 
QSAR approaches. It can be easily generalized to any LMO cross-validation 
protocol but, for the sake of simplicity, the algorithm presented here lies within 
the context of a simpler approach: the LOO procedure.
In its basic formulation, the LOO-CV procedure can be applied when 
a ﬁxed set of descriptors is considered for a set of n molecules. For each 
molecule, a model is built considering the experimental property value of the n-
1 remaining compounds and the respective descriptors. Then, this model is used 
to make a prediction for the molecule left out. The above primary algorithm is 
named here the kernel of the standard LOO-CV method. This kernel algorithm 
can be applied using linear or non-linear methods such as Neural Networks5,6, 
among others more sophisticated such as molecular ﬁeld analysis7,8.  When the 
ordinary MLR method9 is considered, it is not necessary to explicitly construct 
all the linear and independent models to obtain the n predictions: data can be 
obtained from a single MLR calculation since speciﬁc theorems are described 
in the context of LOO and LMO protocols10,11 allowing to readily obtain all the 
cross-validated property values.
Nevertheless, a crucial point is that the protocol usually followed in 
a MLR-QSAR study consists in repeating the LOO kernel calculations 
considering a usually large number of descriptor subsets taken form a large 
pool of parameters. In this way, the ﬁnal cross-validated predictions arise from 
the best descriptor set which gives the most satisfactory result. Generally, the 
reliability of the study is reﬂected by a statistical parameter such as q(2), the 
PRESS statistic or the squared correlation coefﬁcient for the cross-validated 
properties, r2
cv
.12-18 In the evaluation of these statistical parameters the 
experimental molecular properties are considered in an indirect fashion. For 
this reason, the standard LOO/LMO procedures can be understood as a variable 
selection method with indirect property supervision. This characteristic confers 
this kind of CV protocols undesirable features, as some of those pointed out 
by Wold3,4. For instance, this author does not recommend selecting variables 
unless this selection is not associated with the molecular properties. Of course, 
this situation has some advantages as it helps to choose the number and kind of 
parameters to be considered in a QSAR study.6,19,20
The situation described above is also related to a common problem arising 
in a QSAR study: overparametrisation. This is so because the ﬁnal accepted 
and cross-validated model arises from a large number of tests done in order 
to provide an optimal statistical indicator. Then, the question is: Is the best 
result a consequence of chance correlations?21 It is well known that there are 
several useful post-treatment techniques to study this problem. The best known 
is the randomisation test4,22. This control procedure can be mainly implemented 
in two different and extreme ways:4 the randomisation test is applied only to 
the ﬁnal model (this can be understood as a mere model validation) or, more 
desirable, all the calculations are repeated with the free generation of new 
models involving descriptors from the entire pool of parameters (full method 
validation).
The literature has plenty of QSAR results obtained via LOO or LMO 
protocols. The main idea involved is awareness of the whole structure of the 
study, especially if the number of descriptors is considerable and if, at some 
level, variable selection methods are applied. Additionally, if present, the 
randomization test design has to be checked. Finally, the reported statistical 
parameters (q(2), r2
cv
,...) do not directly reﬂect the eventual predictive 
performance of the QSAR model against an external molecular test set.
METHOD
The necessity of obtaining reliable QSAR models led the authors to 
reconsider the LOO/LMO protocol design. The internal test sets (ITS) method 
proposed here takes the idea from the concept of the external validation test 
sets. At the end of the numerical process which will be described below, every 
molecule will bear a single predicted property value (or many of them in the case 
of a LMO-like protocol) which can be compared to the experimental one. The 
performance of the methodology can be measured by means of the correlation 
coefﬁcient of both series of values. We will denote this coefﬁcient r
ITS
. The aim 
of this internal validation test is to provide a new statistical parameter. This is 
so because the r
ITS
 statistic is expected to measure the true predictive power of 
a given QSAR approach more realistically.
The ITS algorithm is simple and general and has been described 
elsewhere.23-26 As shown below, it is very easy to extend this approach to the 
LMO formalism but, for the sake of simplicity, it will be described within the 
paradigmatic framework of a LOO protocol. The algorithm, which must be 
applied on a molecular set, proceeds as follows:
1. Consider n molecules, a pool of indexes describing them and the respective 
property values.
2. Loop: for each molecule (one at a time) do 
2.1. Deﬁne an internal test set containing this molecule and construct an 
internal training set with the n-1 remaining ones.
2.2. Obtain a QSAR CV model from the data available in the internal training 
set.
2.3. Make a prediction for the internal test molecule using the previous model.
3. Collect all the internal predictions and obtain the correlation coefﬁcient, 
r
ITS
, against the experimental values.
For each molecule, the prediction made in step 2.3 is kept as a deﬁnitive 
result. That is the crucial ITS method concept and the main difference with 
respect to the standard LOO/LMO procedures: the prediction for the internal 
test molecule is deﬁnitive because this compound acts as a validation test set 
temporarily, behaving as a true external object for which a real prediction has 
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to be made. From now on, we will call an ITS step the processes involved in 
the loop 2 of the ITS algorithm described above. Consequently, an ITS step 
consists of the test molecule selection, the corresponding model construction 
(involving only the remaining ones), and the respective prediction.
If the algorithm above is followed, in every ITS step the concept of model 
construction at stage 2.2 can be freely interpreted by using the data related to the 
n-1 internal training molecular set. The model construction can be conceived 
in a general way. It can involve embedded procedures of variable selection, 
dimensionality reduction, randomisation tests, other CV techniques, linear or 
non-linear methods, and so on. In this way, the internal training molecular data 
can be freely manipulated. On the other side, the key idea is that, in every 
ITS step, the internal test molecule must act as a true validation object and its 
information must be temporally hidden to the calculation system, especially 
in step 2.2.
The important concept is that the ITS procedure embeds an external loop 
which generates the test molecule (or test molecules in a LMO protocol) and 
an internal procedure which determines the model to be applied over this test 
set. If needed, this internal loop (step 2.2 above) may expand the generation 
of descriptor combinations entering the models, as shown below. This design 
differs from the classical (and most commonly used) CV procedure, which is 
equivalent to having an external loop generating combinations of descriptors 
and an internal loop generating the predictions. This important conceptual 
difference is explained in references 23 and 26.
In the calculations presented below, a standard MLR-LOO method is 
considered in step 2.2 to select a model. That is, for every internal test molecule 
the remaining n-1 ones are left apart one at a time and, for each one, models 
involving information of n-2 compounds are generated. This internal standard 
LOO protocol is followed using, as customary, a quite large set of descriptors. 
Then, at each stage, the best set of descriptors is selected according to the 
r
cv
 value (also denoted r
LOO
 or r
LMO
 in the literature). Finally, a linear model 
involving the n-1 molecules is obtained and the prediction for the internal test 
molecule is made in step 2.3. This process is repeated n times, generating at 
each ITS step a different linear model attached to every internal test molecule.
The process of model and prediction generation can be automatically 
performed or it can be user-supervised. The last option is preferred because the 
data generated can help to detect the system instabilities, outliers, representative 
parameters, optimal number of descriptors to consider or, in general, to grasp 
useful system information. As the ITS method requires constructing QSAR 
models when training set molecules are temporally excluded, the procedure is 
somehow related to the Jackknife technique.27,28 That is, the process of molecule 
hiding in step 2.1 above can serve to analyse the procedure behaviour or 
stability against compound inclusion/exclusion. Another interesting feature of 
the ITS method is related to the commonly encountered problems of overﬁtting 
or the generation of chance correlations. Intrinsically, the researcher who wants 
to perform an ITS procedure is really encouraged by the method to use good 
descriptors, to apply an efﬁcient methodology, and to generate reliable QSAR 
models in step 2.2. If these requirements are not met, the numerical predictions 
in step 2.3 will be very poor and the ﬁnal value of r
ITS
 obtained in the last step 
3 will be almost zero... or even negative. By using the ITS algorithm the user is 
automatically penalised if its methodology allows overparametrisation, chance 
correlations or if the so-called outliers are present in the data. On the other 
hand, if the protocol is followed and an acceptable result (high value of r
ITS
) is 
obtained in step 3, the absence of overﬁtting should be accepted in the study. 
Thus, this kind of results will show that the selected QSAR parameters are 
relevant, that they contain signiﬁcant information, and that the obtained models 
have a real predictive power.
The ITS method is a demanding and time-consuming internal validation 
test because it requires generating true predictions for every test molecule (or 
for every cross-validated test set in a LMO approach). In fact, despite the ITS 
method is an internal validation test, in the context of the LOO methodology 
it can be understood as the generator of a set of n artiﬁcial external validation 
processes. The consequence is that the procedure is about n times slower 
than a typical LOO calculation. That is the consequence of computing the 
r
ITS
 parameter. Nevertheless, this parameter can help us to achieve a very 
desirable goal: to really measure the performance or efﬁciency of a QSAR 
methodology when it is focused on making real predictions for an eventual 
external molecular test set. This is so because the excluded molecules, during 
the internal test set generation, act as true external compounds for which a real 
prediction has to be made.
Another consideration must be stated here. Usually, the obtained values of 
r
ITS
 are small, as shown below. In fact, a bad result can lead to a negative value 
of this parameter, especially if randomisation tests are performed to validate 
the whole ITS methodology. For this reason, r
ITS
 values are reported instead 
of their squares. 
RESULTS AND DISCUSSION
The ITS approach has been applied to study the afﬁnity of a series of 31 
steroids interacting with the corticosteroid binding globuline (CBG). This 
steroid series has been widely used as a benchmark set for testing various 
theoretical QSAR methodologies.7,8,18,20,29-47 That is the reason why this 
molecular set was selected for application. For the same reason, the molecular 
structures are not drawn here. Direct information can be retrieved from the 
cited literature. For this set, a standard LOO study can be found in reference 
(47) where a value of r2
cv
=0.846 (r
cv
=0.920) was obtained for a model involving 
4 linear descriptors. In both, the present work and the reference, Topological 
Quantum Similarity Indexes (TQSI) are used as molecular descriptors.45,47,48-50 
Nevertheless, attention is not focused on the source of molecular descriptors 
but on the concept of the ITS method.
In order to have available data related to predictions over an external test set, 
the well-known problem consisting in modelling the ﬁrst 21 steroids (training 
set) are dealt with and predictions for the remaining 10 ones (true external 
test set) are made. Concerning this approach, many studies can be found in 
the literature. Some of the predictions and related data are shown in Table I. 
Here, the r2
cv
 and q(2) values are the cross-validated correlation coefﬁcient or the 
value of q(2) (also denoted q2 or Q2 in the literature) obtained when the model is 
build from the 21 training molecules. For instance, Hahn and Rogers34 report a 
value of q(2) or r2
cv
 equal to 0.628, which was obtained using a receptor surface 
model (RSM). Klebe et al.30 obtained a value of 0.665 using CoMSIA. Cramer 
and co-workers7, using CoMFA, obtained a value of 0.662 when predictions 
are made from the mean values coming from different atom probes. Chen et 
al.44 reported a value of 0.806, using PARM. Bravi et al.20 obtained the values 
0.605 and 0.729, respectively, by means of MS-WHIM and CoMFA. Jain et 
al.33 reported a value of 0.89, using Compass. The available data of Robinson 
and co-workers8 using SOMFA method or Similarity Matrix Analysis (SMA) 
are also tabulated. Robert et al., using Tuned Molecular Quantum Similarity 
Matrices (TQSAR), report a value of 0.832 for a linear six-parameter model.46 
Finally, there is a column of predictions obtained by Liu and co-workers19 
using MEDV-13, a method based on electrotopological state indexes.
In Table I, RMSE is the root of the mean squared error for the 10 
predictions and r
test
 is the correlation coefﬁcient attached to the ﬁtting of these 
values against the corresponding experimental ones. The series of r
test
 values 
are duplicated: the ﬁrst entry considers the 10 predictions and the second one 
shows how the results are systematically improved if the prediction for the 
molecule number 31 (2a-methyl-9a-ﬂuorocortisol) is not taken into account 
in any of the ﬁnal tests. In the literature this molecule has been described as 
an outlier or an anomalous compound mainly due to the presence of a ﬂuorine 
atom.7,18,29,35,45-47
J. Chil. Chem. Soc., 53, Nº 3 (2008)
1578
Table I: Bibliographic and present results of the property value prediction for the 10 last steroids (external test set). The authors’ references are cited in 
the text. RMSE is the root of the mean squared error. r
test
 is the correlation coefﬁcient between experimental and predicted values. r
ITS
 stands for the correlation 
coefﬁcient between the 21 predictions arising from ITS algorithm and the experimental values.
Steroid
Exp.
activity
Other references This work
Hahn
Rogers
Klebe
et al.
Cramer 
et al.
Chen
et al.
Bravi
et al.
MS-
WHIM
Bravi
et al.
CoMFA
Jain
et al.
Robinson 
et al.
SOMFA
Robinson
et al.
SMA
Robert
et al.
Liu
et al.
1 desc. 2 desc. 3 desc.
22 7.512 7.505 7.40 6.984 7.449 7.300 7.883 7.062 7.279 7.453 7.237 8.166 7.635 7.290 7.775
23 7.553 4.083 7.42 7.764 8.037 8.332 7.430 7.729 7.034 7.022 7.879 7.553 8.836 6.285 7.522
24 6.779 6.575 7.04 6.723 6.601 6.821 6.642 6.462 6.925 6.939 6.648 7.652 6.778 5.492 5.934
25 7.2 6.975 6.65 7.460 6.015 7.445 7.705 7.466 7.232 7.146 7.809 7.765 7.15 6.146 6.853
26 6.144 6.060 6.44 6.156 6.246 6.121 6.495 5.994 5.744 5.908 6.832 5.659 5.007 5.388 5.048
27 6.247 6.720 5.32 7.145 5.742 6.901 6.962 6.383 6.800 7.046 7.318 6.666 7.263 6.014 6.395
28 7.12 6.520 6.89 5.453 6.925 6.532 6.848 6.625 6.603 6.569 7.363 7.340 6.778 6.374 6.581
29 6.817 6.461 6.74 6.958 6.100 6.838 6.816 7.403 6.692 6.850 7.540 5.740 5.836 5.917 5.794
30 7.688 7.070 7.72 7.461 6.108 7.860 7.767 7.741 7.345 7.539 7.628 7.642 8.092 8.478 8.871
31 5.797 6.049 3.78 7.331 5.991 7.491 7.793 7.779 7.283 7.457 7.537 6.845 8.577 7.603 8.429
RMSE
1.153
1.213
0.740
0.395
0.800
0.671
0.709
0.744
0.662
0.411
0.716
0.356
0.705
0.339
0.585
0.367
0.640
0.385
0.762
0.555
0.650
0.590
1.138
0.762
1.015
0.884
1.086
0.735
r2
test
0.003
– 
0.757
0.707
0.045
0.172
0.335
0.303
0.277
0.628
0.154
0.657
0.154
0.687
0.192
0.61
0.118
0.504
0.157
0.359
0.441
0.561
0.100
0.575
0.106
0.563
0.141
0.755
r
test
0.055
-0.029
0.870
0.841
0.212
0.415
0.579
0.550
0.526
0.792
0.393
0.811
0.392
0.829
0.438
0.781
0.343
0.71
0.396
0.599
0.664
0.749
0.317
0.758
0.326
0.750
0.375
0.869
r2
cv
 or 
q(2)
0.628 0.665 0.662 0.806 0.605 0.729 0.89 0.832 0.466 0.626 0.692
r
cv
0.792 0.815 0.814 0.898 0.778 0.854 0.94 0.912 0.683 0.791 0.832
r2
ITS
0.320
0.456
0.166
0.219
0.039
0.388
r
ITS
0.565
0.675
0.407
0.468
0.197
0.623
In Table I, r
ITS
 is the correlation coefﬁcient between the experimental 
values and the 21 internal predictions arising from the ITS algorithm when 
applied over the training set. The r
ITS
 values increase if molecule number 1 
(aldosterone) is not taken into account (see the second entry for each item). 
This gives the researcher a clue with respect to the uniformity of the data 
along the training set, and to the possible classiﬁcation of molecule 1 as an 
outlier. The cross-validated predictive coefﬁcient value for the 21 molecules, 
q(2), is substantially higher than the r
ITS
 one. Nevertheless, the r
ITS
 coefﬁcient 
will be generally more similar to the r
test
 parameter unless some speciﬁc test 
molecules are removed or any other particular manipulations are performed 
over the training set. Among others, Shao51 warned that the classical LOO 
procedure (and hence, the q(2) coefﬁcient) tends to overestimate the predictive 
capability of a method. In fact, the direct relationship between the standard 
correlation coefﬁcient and the one arising from a common LOO calculation 
was recently demonstrated.52 The ITS methodology does not overestimate the 
model predictive ability, as the optimisation of the r
ITS
 coefﬁcient is a task 
harder than maximizing the standard r
cv
 or q(2) values. This is so because in 
the ITS methodology the relationship between the predicted and experimental 
values is very weak. A speciﬁc r
ITS
 optimization procedure was not taken into 
account in this work, that is, all the ITS results presented here were obtained 
“on the ﬂy” from a single prediction for each molecule and no post-treatment 
has been done.
The main conclusion is that the new numerical values of r2
cv
 or q(2) in Table 
I do not directly reﬂect the true prediction ability of each methodology. In fact, 
Table I shows that these parameters are much greater than the corresponding 
test ones, and a similar behaviour can be found in the literature. For instance, 
So and co-workers53 reported several values of the statistic r2
test
 using different 
methodologies in the study of a set of 56 steroids (43 training and 13 for test). 
The values of r2
test
 ranged from 0.108 up to 0.526 and the range rose up to 
0.127–0.610 when some outliers were removed. In the respective trainings the 
values of r2
cv
 or q(2) were 0.590–0.880, substantially higher quantities and closer 
to the training performances.
The most valuable parameter appearing in Table I is the correlation 
coefﬁcient, r
test
, because it arises from the predictions over the legitimate 
external molecular test set. In general, this value is substantially lower than 
the corresponding r
cv 
one, as shown in Table I. Thus, the following chain of 
inequalities must be expected when a molecular set is treated using the same 
protocol and molecular descriptors:
                                                     (1)
In equation (1), r
cv
 can also be interpreted as the square root of q(2). In fact, 
the proposed correlation coefﬁcient, r
ITS
, belongs to the same category of cross-
validation parameters (because it is obtained from a cross-validation procedure 
among the training molecules) but, by construction, this quantity is expected 
to be lower than the other commonly used cross-validation performance 
indicators above. Consequently, the r
ITS
 value should be closer to the r
test
 one. 
For instance, Table I shows the data related to the three models presented 
in this study. The respective inequalities in (1) for the model involving only 
one descriptor (ﬁtting and making a prediction for all the 10 test molecules) 
are 0.740 > 0.683 > 0.565 > 0.317. Another (quite opposite) case is the one 
reported by Hahn and Rogers: despite the value of q(2) is high (0.628), the value 
for r
test
 is negative. The corresponding r
ITS 
value (not computed by the author) is 
expected to be very small and, in this case, it could a priori reveal the potential 
bad methodology performance against a real external test set.
The values of r
test
 in Table I can also be compared to other common values 
of r2
cv
 or q(2) given by several authors for the training set of 21 steroids: Oprea 
et al.32 reported a value of 0.70 (MTD method); Silverman and Platt31, using 
CoMMA and 3 components, obtained 0.828 and 0.674 with 2 components; 
Kellogg and co-workers36 obtained 0.803 (3 components using the 
electrotopological state approach); Turner et al.40 obtained 0.83 (2 components 
and EVA method); Tominaga and Fujiwara43, with 3 descriptors, reached the 
value of 0.807. Finally, in Amat et al. work18, values of r2
cv
 of the order of 
0.842 are given. Generally speaking, these researchers focused their attention 
on maximising the r2
cv
 or q(2) values, but this does not warrant the maximisation 
of the r
test
 value, the ultimate relevant parameter. Although the same is valid 
for the r
ITS
 statistic (its maximisation is not equivalent to optimising the r
test
 
parameter) the maximisation of the r
ITS
 parameter is expected to be more 
correlated to the optimisation of the r
test
 one.
As stated above, three multilinear models are considered in this work. 
Each model involves, respectively, 1, 2 or 3 independent TQSI descriptors 
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selected from a collection of 119. The corresponding values of r
ITS
 shown in 
Table I are 0.565, 0.407 and 0.197, respectively (the model with 4 descriptors 
produced an even worse result than 0.197). In each case, the molecule number 
1 (aldosterone) has an attached bad prediction. This is shown in Figure 1 where, 
for the set of 21 training molecules, the predicted activities by the ITS models 
involving one descriptor are represented against the experimental ones. The 
ﬁgure reveals several instabilities, but it is necessary to recall that every point 
in the graph represents a true external test prediction. In the three linear models 
presented here, if aldosterose is not considered, the values of r
ITS
 systematically 
increase to 0.675, 0.468 and 0.623, respectively (see the second entry in Table 
I). As stated above, the correlation coefﬁcient r
ITS
 is statistically expected to 
be smaller than the corresponding r
cv
 parameter values (r
cv
 is 0.683, 0.791 and 
0.832, for each respective model), but the r
ITS
 value shows the predictive ability 
more realistically. For instance, in constructing linear models involving TQSI, 
the value of r
cv
 increases up to 0.932 if 4 descriptors are considered, or even up 
to 0.940 for a model involving 5 descriptors. Whereas, the ITS methodology 
reveals that, if no other information is available, the most predictive option is to 
consider a smaller number of terms in the linear model. This does not seem to 
be a particularity of this study. The related results concerning other molecular 
families will be published elsewhere.
Figure 1 Internally predicted activities by ITS algorithm against the 
experimental ones for the set of 21 training molecules. The result was obtained 
using TQSI as descriptors and one-descriptor MLR models.
In the ITS algorithm context, the linear models generated to predict 
the property for every test molecule are different. This confers the method 
another characteristic to be checked and evaluated. Regularity of appearance 
is desired among the indexes selected to construct the models, whereas the 
presence of ﬂuctuations is more suspicious. For instance, a desirable regularity 
among the predictive models is found in this study because, in the 21 internal 
predictive models, the same index (except in two cases) appears in the model 
of 1 descriptor: the topological connectivity index54 of order 0, denoted here 
as 1χ
0
(T). This index is used to build the ﬁnal QSAR training model. For this 
particular case and due to the index simplicity, the model ﬁtting and predictions 
can be easily reproduced.55 Other kinds of TQSI connectivity indexes45,47-50 
play an important role for the models of 2 and 3 descriptors and are regularly 
selected. The ﬁnal training models are the following:
pK = 0.525644 1χ
0
(T) - 2.30274
n=21, r2
ﬁt
=0.548, r2
cv
=0.466,  F=16.58, p=0.0007, q(2)= 0.462, 
PRESS=14.878, r
ITS
=0.565
pK = 20.4893 8χ
p
(C) - 23.6851 9χ
p
(C) - 1.31793
n=21, r2
ﬁt
=0.682, r2
cv
=0.626, F=31.82, p<0.0001, q(2)=0.624, 
PRESS=10.388, r
ITS
=0.407
pK = 0.451322 1χ
p
(C) + 14.4145 8χ
p
(C) - 17.2569 9χ
1
(C) - 3.04739
n=21, r2
ﬁt
=0.769, r2
cv
=0.692, F=42.69, p<0.0001, q(2)=0.69, PRESS=8.583, 
r
ITS
=0.197
Finally, randomisation tests are considered as a tool to a priori select the 
best among the three previous models. Figure 2 presents the obtained values of 
r
ITS
 when 120 random calculations (artiﬁcially exchanging molecular property 
values) are performed in constructing models involving 1 (a), 2 (b) or 3 (c) 
descriptors. For each drawn point, an automated full ITS study was made and 
the system had full freedom to re-select descriptors from the entire data set from 
the beginning. Hence, this is not a ﬁnal model test (as mentioned above) but 
a methodology test, a much more desirable procedure for checking purposes. 
In each graph, the random points ﬁt a gaussian distribution also graphically 
represented. The horizontal segments appearing in the gaussian curve signal 
the position of the points lying to 1, 2 or 3 standard deviation values from 
the centred mean one (almost zero in all the cases). The upper horizontal line 
signals the correct value of r
ITS
. The standardisation of this value according 
to the respective gaussian distribution gives a measure of the randomness 
of the deterministic result. The percentages attached to the upper tails (the 
error levels) are 0.1%, 0.3% and 8.2% for the 1, 2 and 3 descriptor models, 
respectively. The ﬁrst case gives the most reliable result. Thus, statistically 
speaking, the predictions on the 10 test molecules using the single descriptor 
model is the most robust result according to the ITS protocol. This agrees with 
the fact that the single parameter model gives the highest r
ITS
 value.
Figure 2 Randomisation tests considering models of 1 (a), 2 (b) and 3(c) 
descriptors by model. Each point is attached to a full ITS procedure calculation. 
The random points follow a gaussian distribution (depicted). The horizontal 
line depicts the actual result which can be contrasted against the normal 
distribution (see text).
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CONCLUSIONS
The ITS methodology is presented and its advantages revealed when 
comparing predictions and CV methodologies in the literature. This study was 
undertaken considering a well-known benchmark molecular set, the so called 
Cramer steroids, a set of 31 steroids interacting with the corticosteroid binding 
globuline. The relevant conclusion is that the ITS method serves to direct 
the model construction to a minimum overparametrisation degree, providing 
the r
ITS
 parameter, which measures the predictive ability of the methodology 
with respect to a potential external or validation molecular set. This predictive 
capability quantiﬁcation appears to be more realistic than the ones obtained 
from other cross-validation parameters, as r
CV
 or q(2) terms.
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